Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs Vanguard Growth Index Fund ETF (VUG) Price & Performance

Amylx Pharmaceuticals IncTrade
Vanguard Growth Index Fund ETFTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Vanguard Growth Index Fund ETF — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Vanguard Growth Index Fund ETF trades at $89. Which is the better fit depends on your goals.

AMLXVUG
Market Cap
$2.64B
Sector
HealthSector/Thematic
52-Week High
$24.19$90.29
52-Week Low
$7.82$70.00
Enterprise Value
$2.39B

Returns comparison

Trailing returns across standard periods

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About Vanguard Growth Index Fund ETF

VUG is an index-based ETF that tracks the CRSP US Large Cap Growth Index, providing concentrated exposure to the largest and fastest-growing companies in the United States. It focuses on stocks with high growth potential across tech, communication, and consumer sectors, serving as a low-cost, high-conviction core holding for long-term capital appreciation.

Read more on VUG